NutriStack
Chromium and Dapagliflozin, a caution.
Dapagliflozin reduces blood glucose by promoting urinary glucose excretion, and chromium improves insulin sensitivity. On dapagliflozin alone the hypoglycemia risk is low, but adding chromium to a regimen that already contains insulin or a sulfonylurea can produce symptomatic lows.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Chromium and Dapagliflozin
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. Dapagliflozin reduces blood glucose by promoting urinary glucose excretion, and chromium improves insulin sensitivity. On dapagliflozin alone the hypoglycemia risk is low, but adding chromium to a regimen that already contains insulin or a sulfonylurea can produce symptomatic lows.
Mechanism. Dapagliflozin inhibits SGLT2 in the proximal renal tubule, increasing glycosuria. Chromium enhances insulin receptor signaling and GLUT4-mediated glucose uptake in skeletal muscle. The two effects are additive.
Recommendation. If dapagliflozin is your only diabetes medication, chromium can be added with home glucose monitoring during the first 2-4 weeks. If you also take insulin or a sulfonylurea, ask your prescriber whether the other agent should be reduced before starting chromium.
Sources (2)
- Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther. 2006;8(6):636-43. PMID 17109595
- Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14. PMID 15208835
Stack Score
How this pair moves the number.
Effect on the composite score
If both Chromium and Dapagliflozin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.